Evidence map›Paper›PMID 32214809›Full record

ArticleInternational journal of nanomedicine2020

EWVDV-Mediated Platelet-Targeting Nanoparticles for the Multimodal Imaging of Thrombi at Different Blood Flow Velocities.

Jie Xu, Jun Zhou, Yixin Zhong, Yu Zhang, Man Ye, Jingxin Hou, Zhigang Wang, Haitao Ran, Jia Liu, Dajing Guo

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Immunomodulation in age-related disorders and nanotechnology interventions.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2023
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jie XuDepartment of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Jun ZhouDepartment of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Yixin ZhongDepartment of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Yu ZhangDepartment of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.ORCID 0000-0002-2943-6006
Man YeDepartment of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Jingxin HouDepartment of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Zhigang WangInstitute of Ultrasound Imaging, Department of Ultrasound, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Haitao RanInstitute of Ultrasound Imaging, Department of Ultrasound, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Jia LiuDepartment of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Dajing GuoDepartment of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere have been many recent reports of molecular probes for thrombi but with unsatisfactory in vivo targeting effects, which could be related to the blood flow velocity in vivo. Therefore, it is worth explaining the relationship between the targeting effect and the blood flow velocity. METHODS AND MATERIALS: In this study, we constructed a platelet-targeting nanoparticle (NP) based on EWVDV for targeting P-selectin combined with the phase transition material perfluorohexane and India ink to achieve the multimodal imaging of thrombi. We studied the targeting effect of the NPs for rabbit blood thrombi under different flow velocities simulating blood flow velocities in vivo.

resultsThe results show the successful fabrication of NPs with the ability to undergo a phase transition via low-intensity focused ultrasound irradiation to achieve ultrasound imaging and with a high binding affinity for activated platelets. In vitro, low flow velocities (20 cm/s) hardly affected the targeting effect of the NPs, while moderate flow velocities (40 cm/s) reduced the number of NPs that target thrombi by 52.6% comparing to static fluid (0 cm/s). High flow velocities (60 cm/s) greatly reduced the targeting effect of the NPs by 83.5%.

conclusionThese results can serve as a reference for the design of NPs targeting thrombi at different sites and in different blood vessel types according to the blood flow velocity, thereby establishing a foundation for in vivo experiments.

Indexed as

AnimalsBlood Flow VelocityBlood PlateletsCarbonFluorocarbonsMultimodal ImagingNanoparticlesPlatelet ActivationPolylactic Acid-Polyglycolic Acid CopolymerP-SelectinRabbitsThrombosisUltrasonographyCarbonchinese inkFluorocarbonsperflexanePolylactic Acid-Polyglycolic Acid CopolymerP-Selectinblood flow velocitymultimodal imagingphase transitionthrombus

Identifiers

PMID32214809
PMCPMC7083630
OpenAlexW3012103272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.